BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37194712)

  • 1. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
    Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
    Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitors or cyclophosphamide in the treatment of membranous nephropathy superimposed with FSGS lesions: a retrospective study from China.
    He HG; Huang YY; Liang QQ; Ye QR; Li AD; Ye K; Wu QX; You YW
    Ren Fail; 2023; 45(2):2253930. PubMed ID: 37724535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to immunosuppressive therapy in PLA
    Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
    BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
    Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
    BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage.
    Sun M; Li P; Dong J; Li Z; Li C; Zhang S; Chen B
    Ren Fail; 2023 Dec; 45(1):2205951. PubMed ID: 37125531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
    Qiu TT; Zhang C; Zhao HW; Zhou JW
    Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
    Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
    BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the efficacy of different treatments for idiopathic membranous nephropathy: a retrospectively real-world study.
    Sun M; Huang J; Dong J; Li Z; Li C; Zhang S; Chen B
    Curr Med Res Opin; 2023 May; 39(5):761-769. PubMed ID: 36938631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and clinical significance of glomerular M-type phospholipase A
    Liu H; Luo W; Gong S; Ding X
    Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy.
    Zou H; Jiang F; Xu G
    Ren Fail; 2019 Nov; 41(1):673-681. PubMed ID: 31354007
    [No Abstract]   [Full Text] [Related]  

  • 18. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
    Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
    Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive Treatments for Idiopathic Membranous Nephropathy: A Pilot Study According to Histopathological Stages.
    Yan Z; Hu L; Xu G
    Am J Med Sci; 2022 May; 363(5):444-451. PubMed ID: 34606753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.